Regarding tumor differentiation, this study found that EGFR mutations were more common in moderately differentiated adenocarcinomas and rare in poorly differentiated tumors, which slightly differs from previous research suggesting a lower mutation rate in poorly differentiated cases (45). This evidence concerns the gene EGFR and adenocarcinoma.